Stay updated on Mepolizumab in Severe Asthma: Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab in Severe Asthma: Clinical Trial page.

Latest updates to the Mepolizumab in Severe Asthma: Clinical Trial page
- Check6 days agoChange DetectedAdded user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment-status notice. The Intervention/Treatment heading was standardized and the revision identifier updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check13 days agoChange DetectedThe page's revision label in the footer was updated from v3.5.4 to v3.5.5, signaling a small site update.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedA new publication citation about cost-effectiveness of mepolizumab in Chinese patients with severe asthma was added to Publications, and the page revision was updated from v3.5.3 to v3.5.4.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page revision indicator was updated from **v3.5.0** to **v3.5.3**, reflecting a site/application release update rather than a change to the study record content.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This update reflects page versioning and does not modify the study details or user-facing content.SummaryDifference0.0%

- Check106 days agoChange Detected- Added Revision: v3.4.3; removed Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Mepolizumab in Severe Asthma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab in Severe Asthma: Clinical Trial page.